Research map: The Impact of Dutasteride Treatment on Subsequent Multiparametric Prostate Magnetic Resonance Imaging Sequences and PI ‐ RADS Score in Patients With PI ‐ RADS 3 Lesions in the Transitional Zone

Back to the article

Papers in this map

  1. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2 · Barış Türkbey · 2019 · 2532 citations · Cited by this paper
  2. Comprehensive Genomic Characterization Between Urothelial Carcinoma Subtypes/Divergent Differentiation (S/ DD ) and Pure Urothelial Carcinoma Using a Large‐Scale Japanese Genomic Panel Dataset · 2026 · Related
  3. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent · Philip A Cornford · 2024 · 1253 citations · Cited by this paper
  4. Cancer‐Associated Fibroblasts Promote Development of Papillary Renal Cell Carcinoma by Inducing Histone Lactylation of RBM15B to Modify in an m6A ‐Dependent Manner on ANLN · 2026 · Related
  5. MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial · Francesco Giganti · 2017 · 36 citations · Cited by this paper
  6. Long‐Term Oncologic Outcomes After Laparoscopic Radical Nephroureterectomy: A Contemporary Analysis From a Japanese Multicenter Cohort · 2026 · Related
  7. Prostate cancer detection using quantitative T2 and T2‐weighted imaging: The effects of 5‐alpha‐reductase inhibitors in men on active surveillance · Francesco Giganti · 2017 · 22 citations · Cited by this paper
  8. Diabetes Is an Independent Risk Factor for Radiation‐Induced Hematuria After Robotic Stereotactic Body Radiotherapy for Prostate Cancer · 2026 · Related
  9. Magnetic Resonance Imaging–Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE) · Laurence H. Klotz · 2023 · 19 citations · Cited by this paper
  10. Artificial Intelligence–Based Objective Evaluation of Nerve‐Sparing Status Combined With Preserved Urethral Length Predicts Urinary Continence Recovery After Robot‐Assisted Radical Prostatectomy · 2026 · Related
  11. The effect of 5 alpha-reductase inhibitor therapy on prostate cancer detection in the era of multi-parametric magnetic resonance imaging · Jung Kwon Kim · 2019 · 17 citations · Cited by this paper
  12. Real‐World Outcomes of Radium‐223 Therapy in Metastatic Castration‐Resistant Prostate Cancer: Predictive Value of PSA Doubling Time and Enzalutamide Continuation · 2026 · Related
  13. PI-RADS version 2.1 for the evaluation of transition zone lesions: a practical guide for radiologists · Caterina Gaudiano · 2021 · 16 citations · Cited by this paper
  14. Efficacy of Testosterone Replacement Therapy Combined With Exercise on Body Composition in Hypogonadal Men · 2026 · Related
  15. Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors · Ugo Giovanni Falagario · 2023 · 12 citations · Cited by this paper
  16. Real‐World Occurrence of Adverse Events Associated With Adjuvant Pembrolizumab Therapy for Renal Cell Carcinoma: A Multicenter Retrospective Study · 2026 · Related
  17. 5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity · Ziting Wang · 2023 · 9 citations · Cited by this paper
  18. Interpreting Sealing‐Device Effects in Retroperitoneal Laparoscopic Adrenalectomy · 2026 · Related
  19. Effect of 5-Alpha Reductase Inhibitors on Magnetic Resonance Imaging and Prostate Cancer Detection · Juan Moróte · 2024 · 5 citations · Cited by this paper
  20. Oncological Outcomes and Prognostic Factors of Platinum‐Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum‐Based Chemotherapy Alone: A Propensity Score–Matched Analysis in a Real‐World Population · 2026 · Related
  21. The cutoff value of transitional zone index predicting the efficacy of dutasteride on subjective symptoms in patients with benign prostate hyperplasia · Shinsuke Kurokawa · 2022 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)